Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Publication|Articles|May 1, 2003

The American Journal of Managed Care

May 2003
Volume 9
Issue 5

Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

Author(s)Darren Kocs, MD, MHSA, A. Mark Fendrick, MD

Download PDF: Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

Articles in this issue

about 23 years ago

Article

Lansoprazole Overutilization: Methods for Step-Down Therapy

about 23 years ago

Article

Reducing Costs and Improving Outcomes of Percutaneous Coronary Interventions

about 23 years ago

Article

Evaluation of a Depression Health Management Program to Improve Outcomes in First or Recurrent Episode Depression

about 23 years ago

Article

A Prediction Model for Targeting Low-Cost, High-Risk Members of Managed Care Organizations

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

AJMC original research clinical

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

AJMC original research clinical

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

June 4th 2026

Orthopedic surgeon holds bone x-ray | Image Credit: © tippapatt - stock.adobe.com

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

ByHannah I. Travers, MD,Mikhail Kuznetsov, MD,John Mazzocco, MD,Nicholas Pagani, MD,Tricia Ide, DNP, RN,Brian L. Hollenbeck, MD,Eric L. Smith, MD

June 3rd 2026

Trending on AJMC

Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata

First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA

5 Notable Oncology FDA Approvals Granted in May

Delgocitinib Coverage Could Save Health Plans $88M Over 3 Years

Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story